A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen ...
Blocking progesterone receptor (PR) activity has long been viewed as a possible approach to breast cancer prevention. Historically, most supporting evidence came from animal models, epidemiological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback